you are here: HomeNewsIndia

Coronavirus update: India's COVID-19 tally rises to 94.31 lakh with 38,772 fresh cases

There are 4,46,952 active cases in India which comprise 4.74 percent of the total caseload.

November 30, 2020 / 11:03 AM IST
File image: Reuters

File image: Reuters

The number of COVID-19 cases reported in India in a span of 24 hours dropped below 40,000 for the seventh time this month, taking the infection tally to 94.31 lakh, while the recoveries surged to 88,47,600, according to the Union Health Ministry's data updated on Monday.

The total coronavirus cases mounted to 94,31,691 with 38,772 new infections, while the death toll climbed to 1,37,139 after 443 more fatalities were reported, the data updated at 8 am showed.

Click here for LIVE updates on coronavirus pandemic

The number of people who have recuperated from the disease surged to 88,47,600, pushing the national recovery rate to 93.81 percent. The COVID-19 case fatality rate declined further to 1.45 percent.

The active COVID-19 caseload remained below five lakh for the 20th consecutive day. There are 4,46,952 active cases in the country which comprise 4.74 percent of the total caseload, the data stated.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

India's COVID-19 tally had crossed the 20-lakh mark on August 7, 30 lakh on August 23 and 40 lakh on September 5.

It went past 50 lakh on September 16, 60 lakh on September 28, 70 lakh on October 11, crossed 80 lakh on October 29, and surpassed 90 lakh on November 20.

According to the ICMR, 14,03,79,976 samples have been tested up to November 29 with 8,76,173 samples being tested on Sunday.

Click here for Moneycontrol's full coverage of the COVID-19 outbreak
PTI
first published: Nov 30, 2020 11:02 am

stay updated

Get Daily News on your Browser
Sections